Muva nje, abacwaningi kusukela China Medical University Taiwan wathola ukusetshenziswa ezivamile sodium benzoate njengoba uyakulondoloza ukudla ekwelapheni sokuphazamiseka kwengqondo. Okusanda eyanyatheliswa ngo-Biological Psychiatry enesihloko esithi "Sodium Benzoate, i-D-Amino Acid Oxidase inhibitor, Kungezwe Clozapine ngokuba Ukwelashwa Schizophrenia: A olwenziwa, kabili abayizimpumputhe, Trial Placebo ezilawulwa [Sodium Benzoate, A D-amino acid oxidase inhibitor kuhlanganiswe nge clozapine ekwelapheni bayasangana: a olwenziwa, placebo-elawulwa, kabili izimpumputhe cwaningo emitholampilo] sihloko sibonisa ukuthi i-sodium benzoate kuyinto refractory ukuze ukumelana clozapine i izimpawu zesifo kahle ngcono eqenjini iziguli bayasangana.
Ngokuphathelene imiphumela yocwaningo, John Krystal, MD, umhleli Biological Neurology futhi onguprofesa Yale University School of Medicine, waveza ukuthi receptor D-noSerine Uyi osekukade target zokwelapha e ukuthuthukiswa bayasangana izidakamizwa eminyakeni. Sodium benzoate cishe ithuluzi yokuqala okunenjongo kufanele ngenkuthalo nomthelela lokhu target.
Shijiazhuang Standard Amakhemikhali Co., LTD ngokukhethekile ukukhiqizwa futhi ukuthekelisa sodium benzoate, sizokunikeza okusezingeni eliphezulu imikhiqizo eyikhwalithi kanye ngemisebenzi emihle. amakhasimende Siyakwamukela ukuxoxisana.
isikhathi Iposi: May-11-2018